Logo

    Peter Groot and Akansha Vaswani - Tapering Strips and Shared Decision-Making

    enJuly 06, 2018
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    On MIA Radio this week, Akansha Vaswani and Dr Peter Groot discuss Tapering Strips, a novel and practical solution for those who wish to taper gradually from a range of prescription drugs.

    Akansha is a doctoral candidate at the University of Massachusetts, Boston and her dissertation research will involve interviewing psychiatrists in the US about their experiences helping people stop or reduce their dose of antidepressant medication. Dr Groot is a researcher and geneticist who has led the development of Tapering Strips.

    In a recent study, published in the journal Psychosis, Dr Groot, together with Jim van Os, reported on the results of their trial which recorded the experiences of people using Tapering Strips.

    In this episode we discuss:

    • What motivated Peter to be interested in and study the effects of coming off antidepressants drugs.
    • That the observational study reported in Psychosis was based on questionnaires completed by users who had made use of tapering medication (Tapering Strips) to slowly reduce their medication dosage.
    • How the questionnaire asked about withdrawal symptoms and the ease of tapering using the strips and whether people had tried to withdraw previously using conventional methods.
    • That Tapering Strips offer a flexible and necessary addition to standard doses that have been registered by the pharmaceutical companies.
    • That current guidelines advise doctors to let patients start on the same recommended dose of an antidepressant, without taking into account large differences that exist between patients (weight, sex, etc).
    • How we would be surprised if, when we came to buy shoes or clothes, our choices were limited to only a few sizes, but we don’t question this limitation with our medications.
    • How current guidelines are based on group averages and do not help a doctor to determine how a given individual patient should taper.
    • How shared decision making, in which the patient and the doctor work in a collaborative way, can make tapering easier.
    • How shared decision making has contributed to the success of the use of tapering medication and the availability of tapering medication makes shared decision making practically possible.
    • How shared decision and the availability of tapering medication makes life easier for the doctor as well as for the patient.
    • How working initially as a volunteer to develop Tapering Strips brought Peter into contact with Professor Jim van Os and the User Research Centre of Maastricht University.
    • That, in the study, 1,750 questionnaires were sent, with 1,164 received, a response rate of 68%.
    • Of those returned, 895 said their goal was to taper their antidepressant drug completely and 70% succeeded in this goal.
    • That the median time taken for people in the study to withdraw from Venlafaxine was 56 days or two Tapering Strips.
    • There were a variety of reasons reported for those who didn’t reach their goal, including the fact that some of the patients were still tapering.
    • Other reasons reported for not withdrawing completely were due to the occurrence of withdrawal symptoms, relapse of an original condition or even issues related to reimbursement of the cost of the tapering medication by insurance companies.
    • That 692 patients reported that previous attempts to withdraw had failed in comparison to the successful use of Tapering Strips.
    • That people using multiple drugs should only ever taper one medication at a time and in discussion with a medical professional.
    • That Peter’s goal for Tapering Strips is to make sure that people that want to withdrawal gradually can access Tapering Strips and have the cost reimbursed by health insurers.
    • That Tapering Strips were not developed to get everyone off their antidepressant drug but to enable patients to get to a dosage that provides benefit for them (which can be zero) while minimising adverse effects.
    • That people outside the Netherlands can get Tapering Medication, but only with a prescription signed by a certified doctor, instructions and receipt/order forms can be found at taperingstrip.org.
    • That Tapering Strips are also available for antipsychotics, sedatives (benzodiazepines), analgesics and for some drugs other than psychotropics, like some anti-epileptic drugs, which are currently being developed.
    • That Peter warns against tapering by taking doses on alternating days, particularly for drugs like paroxetine or venlafaxine that have a short metabolic half-life, because this will lead to more severe withdrawal symptoms.

    Relevant Links:

    Tapering Strips (website of the User Research Centre of Maastricht University)

    Treatment guidelines for the use of tapering strips

    Summary of the tapering study in the journal Psychosis (blog)

    Tapering Strips study from the journal Psychosis

    Peter Groot interviewed on Let's Talk Withdrawal

    Claire shares her experience with Tapering Strips (YouTube)

    Petition requesting use of Tapering Strips in the UK

    Mad in America report on Tapering strips study

    Prime Time for Shared Decision Making

    Mandatory Shared Decision Making

    © Mad in America 2018

    Recent Episodes from Mad in America: Rethinking Mental Health

    Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients - Swapnil Gupta

    Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients - Swapnil Gupta

    Swapnil Gupta is an Associate Professor and Medical Director of Ambulatory Psychiatry at Mount Sinai Morningside Hospital. She was trained as a psychiatrist in India and the United States, at SUNY Downstate Medical Center and Yale University, and PGI Chandigarh in India. She is known for her work on deprescribing from and discontinuation of psychiatric drugs.

    Dr. Gupta’s career began with research on the role of the endocannabinoid system in the pathophysiology of schizophrenia as an academic psychiatrist. Her subsequent scholarship has focused on applying deprescribing, the systematic reduction of unnecessary medications, to psychiatry by rooting it in the principles of recovery-oriented care. She has authored several peer-reviewed papers on deprescribing and co-authored a book with Rebecca Miller and John Cahill.

    She is an active member of two organizations that aim to enhance stakeholder engagement in psychiatric research. She is also a part of the editorial board of the Community Mental Health Journal. Currently, she is working on creating educational resources to help people discontinue psychiatric medications and gathering information on the knowledge and opinions of psychiatrists regarding the discontinuation of such drugs.

    In this interview, we discuss deprescribing from psychiatric drugs, the difficult decisions faced by patients, the importance of psychosocial support during withdrawal, and how deprescribing is central to recovery-oriented practices such as shared decision and patient choice. We will also tackle the complex issue of whether the recurrence of symptoms once a drug is tapered is a mark of relapse or withdrawal caused by the psychiatric medication.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    To find the Mad in America podcast on your preferred podcast player, click here

    Is Madness an Evolved Signal? – Justin Garson on Strategy Versus Dysfunction

    Is Madness an Evolved Signal? – Justin Garson on Strategy Versus Dysfunction

    Justin Garson is a Professor of Philosophy at Hunter College and The Graduate Center, City University of New York, and a contributor for Psychology Today and Aeon. He writes on the philosophy of madness, the evolution of the mind and purpose in nature. His most recent book is Madness: A Philosophical Exploration, published by Oxford University Press in 2022. He is also the author of the forthcoming The Madness Pill: The Quest to Create Insanity and One Doctor’s Discovery that Transformed Psychiatry, which will be published by St. Martin’s Press.

    In this interview, Justin joins us to talk about the ways in which society has attempted to explain or categorize madness over the years. We also discuss the value of looking at madness, not as disease or defect, but as a designed feature.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    To find the Mad in America podcast on your preferred podcast player, click here

    'It Was a Joint Effort'- Deborah Kasdan on Bringing Her Late Sister's Story to Life

    'It Was a Joint Effort'- Deborah Kasdan on Bringing Her Late Sister's Story to Life

    Deborah Kasdan is author of Roll Back The World: A Sister’s Memoir, in which she describes her extraordinary late sister Rachel–poet, musician, free spirit–and her decades-long journey through psychiatric treatment until, finally, she found a place of peace and community. 

    Kasdan is a longtime business and technology writer who pivoted to memoir writing on a quest to tell her sister’s story, joining the Westport Writers’ Workshop. Her book, published in October by She Writes Press, is a moving and nuanced portrait filled with love and grief, candor, and complexity. 

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    To find the Mad in America podcast on your preferred podcast player, click here

    What if Much of What you Thought you Knew About Mental Health was up for Debate?

    What if Much of What you Thought you Knew About Mental Health was up for Debate?

    Hello and welcome to the Mad in America: Rethinking Mental Health podcast.

    If you are new here, hello. My name is James and I will be your host as we ask critical questions about the state of psychiatry and psychology in the 21st Century.

    In this podcast, we examine mental health with a critical eye by speaking with psychologists, psychiatrists, researchers, journalists and people with lived experience.

    When you hear such conversations, you realise that much of what is believed to be settled in mental health is actually up for debate. Is mental health a matter of faulty biology or is there more to it? Are the treatments used in psychiatry helpful or harmful in the long term? Are psychiatric diagnoses reliable? With the help of our guests, we examine these questions and so much more.

    I think you will find the podcast insightful, informative, and, most of all, thought-provoking. It’s available on all major podcast platforms like Spotify, Apple or Google podcasts and YouTube. Just search for Mad in America: Rethinking Mental Health.

    Please join us for these important conversations.

    ***

    Mad in America is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    To find the Mad in America podcast on your preferred podcast player, click here

    The Psychological Humanities Manifesto: An Interview with Mark Freeman

    The Psychological Humanities Manifesto: An Interview with Mark Freeman

    Mark Freeman is a renowned author and a pioneering voice in the emerging field of the psychological humanities. He serves as Distinguished Professor of Ethics and Society in the Department of Psychology at the College of the Holy Cross. His body of work, including the critically acclaimed Toward the Psychological Humanities: A Modest Manifesto for the Future of Psychology (Routledge, 2023), offers a profound reimagining of psychology, interweaving it with the arts and humanities to better understand the human condition.

    He is the author of numerous additional works, virtually all of which, in one way or another, speak to the emerging field of the psychological humanities. These include Rewriting the Self: History, Memory, Narrative (Routledge, 1993); Finding the Muse: A Sociopsychological Inquiry into the Conditions of Artistic Creativity (Cambridge, 1994); Hindsight: The Promise and Peril of Looking Backward (Oxford, 2010); The Priority of the Other: Thinking and Living Beyond the Self (Oxford, 2014); and Do I Look at You with Love? Reimagining the Story of Dementia (Brill | Sense). Along with David Goodman, he has also co-edited Psychology and the Other (Oxford, 2015) and, with Hanna Meretoja, has co-edited the recently published The Use and Abuse of Stories: New Directions in Narrative Hermeneutics (Oxford, 2023). He also serves as Editor for the Oxford University Press series “Explorations in Narrative Psychology.”

    In this interview, we'll explore his personal journey toward the psychological humanities, delve into his work in narrative psychology, and discuss his approach to the concepts of 'self' and the 'Other.' We'll also touch upon how his perspectives guided him as he navigated his mother's journey through dementia, a deeply personal narrative shared in his book.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. To find the Mad in America podcast on your preferred podcast player, click here

    Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

    Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

    On the Mad in America podcast this week, we continue our reader Q&A with Mad in America founder Robert Whitaker. In Part 1, we discussed Mad in America, the biopsychosocial model and the history of psychiatry. For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Thank you to all of you who took the time and trouble to send in your questions.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    To find the Mad in America podcast on your preferred podcast player, click here

    Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History

    Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History

    On the Mad in America podcast this week we have Robert Whitaker with us to answer questions sent in by readers and listeners. Thank you to all of you who took the time and trouble to get in touch. You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    To find the Mad in America podcast on your preferred podcast player, click here

    The Making of a 'Madness' That Hides Our Monsters - An Interview with Audrey Clare Farley

    The Making of a 'Madness' That Hides Our Monsters - An Interview with Audrey Clare Farley

    Audrey Clare Farley is a writer, editor, and scholar of 20th-century American culture with a special interest in science and religion. She earned a PhD in English literature at the University of Maryland, College Park. She now teaches a course on U.S. history at Mount St. Mary’s University.

    Her first book, The Unfit Heiress: The Tragic Life and Scandalous Sterilization of Ann Cooper Hewitt, tells the story of a 1930s millionairess whose mother secretly sterilized her to deprive her of the family fortune, sparking a sensational case and forcing a debate of eugenics. Her second book, which we will be discussing today, Girls and Their Monsters: The Genain Quadruplets and the Making of Madness in America, explores the lives of the four women behind the National Institute of Mental Health’s famous case study of schizophrenia. It was named a New York Times Editors’ Pick and will be the focus of our conversation today.

    Audrey’s essays have appeared in the Atlantic, New York Times, Washington Post, and many other outlets. She lives in Hanover, Pennsylvania.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    Mad in America podcasts and reports are made possible, in part, by a grant from the Thomas Jobe Fund.

    To find the Mad in America podcast on your preferred podcast player, click here

    A Playground for Predators-Diane Dimond on The Abuses of Guardianship

    A Playground for Predators-Diane Dimond on The Abuses of Guardianship

    Like to know more about MIA, its mission or rethinking psychiatry more broadly? On our podcast, MIA founder Robert Whitaker will answer your questions. Email questions to askmia@madinamerica.com by November 10 and we will pick a selection.

    ***

    Our guest today is Diane Dimond, a longtime, award-winning investigative journalist specializing in crime and justice issues. As a freelance journalist, syndicated columnist, and former television correspondent, her reporting and commentary have been featured in newspapers, magazines, and TV news outlets across the country.

    She’s also the author of several books, including Be Careful Who You Love: Inside the Michael Jackson Case, which she wrote after years of groundbreaking reporting on the topic; and her most recent, We’re Here to Help: When Guardianship Goes Wrong, recently published by Brandeis University Press.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    Mad in America podcasts and reports are made possible, in part, by a grant from the Thomas Jobe Fund.

    To find the Mad in America podcast on your preferred podcast player, click here

    May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem

    May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem

    Like to know more about MIA, its mission or rethinking psychiatry more broadly? On our podcast, MIA founder Robert Whitaker will answer your questions. Email questions to askmia@madinamerica.com by November 10 and we will pick a selection.

    ***

    Brooke Siem is a writer, speaker, and advocate for the safe de-prescribing of psychiatric drugs. Her work on antidepressant withdrawal has appeared in The Washington Post, the New York Post, Psychology Today, and many more. She is also an award-winning chef and Food Network Chopped Champion.

    In this interview, we talk about her experiences of withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects, published in 2022 which is one of the first books on antidepressant withdrawal to make it to the mass market.

    ***

    Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

    Mad in America podcasts and reports are made possible, in part, by a grant from the Thomas Jobe Fund.

    To find the Mad in America podcast on your preferred podcast player, click here

     

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io